Loading news...
Loading news...
Series B funding round for Fulcrum Therapeutics raising $80M in September 2018
Series B funding round for Fulcrum Therapeutics raising $80M in September 2018
| Investor |
|---|
| Firm Type |
|---|
| Partner |
|---|
Foresite CapitalLEAD | Venture Capital | — |
| Venture Capital | — | |
| Investment Bank | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Corporate Venture Capital | — | |
| Angel | Krishna Yeshwant |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$135M
Top Valuation
-
Fulcrum Therapeutics raised $80M in a Series B round.
The round was announced on 09/01/18.
The round was led by Foresite Capital.